Neogen Resultados de beneficios anteriores
Pasado controles de criterios 1/6
Los beneficios de Neogen han disminuido a una tasa media anual de -37.7%, mientras que en la industria Medical Equipment los beneficios crecieron en un 13.5% anualmente. Los ingresos han ido creciendo a una tasa media de 18.8% al año. La rentabilidad financiera de Neogen es de 0.05%, y sus márgenes netos son de 0.2%.
Información clave
-37.7%
Tasa de crecimiento de los beneficios
-37.9%
Tasa de crecimiento del BPA
Crecimiento de la industria Medical Equipment | 8.9% |
Tasa de crecimiento de los ingresos | 18.8% |
Rentabilidad financiera | 0.05% |
Margen neto | 0.2% |
Última actualización de beneficios | 29 Feb 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Battered By M&A Integration Issues, Neogen Has To Rebuild Investor Trust
Apr 15Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
Apr 12Neogen (NASDAQ:NEOG) Takes On Some Risk With Its Use Of Debt
Mar 29Neogen: All About Execution From Here On
Mar 26Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are
Jan 17Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
Jan 12Neogen Corporation (NASDAQ:NEOG) Investors Are Less Pessimistic Than Expected
Jan 09Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly
Dec 06Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet
Jul 12Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?
Jun 20Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet
Mar 25Neogen introduces ready-to-use disinfectant Companion RTU for veterinary use
Oct 10Neogen GAAP EPS of $0.05, revenue of $132.35M
Sep 27Neogen drops 9% as merger with 3M’s food safety business closes
Sep 01Broker Revenue Forecasts For Neogen Corporation (NASDAQ:NEOG) Are Surging Higher
Aug 21Neogen: Cut In Half, Still Some Questions
Aug 12There May Be Reason For Hope In Neogen's (NASDAQ:NEOG) Disappointing Earnings
Aug 04Neogen: Thesis Unchanged After Q4 And Full-Year Earnings
Aug 01Neogen FQ4 2022 Earnings Preview
Jul 25Zoetis, IDEXX named as buys in animal health space by Piper Sandler
Jul 13Neogen announces pricing of $350M senior notes offering
Jul 07Neogen: Safety Food Giant In The Making
Dec 15Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends
Dec 12Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends
Sep 12Robust Valuation Leaves Neogen Little Room For Error After Mixed Results
Jul 27Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero Neogen. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
29 Feb 24 | 929 | 2 | 322 | 24 |
30 Nov 23 | 919 | 12 | 354 | 27 |
31 Aug 23 | 919 | -27 | 336 | 28 |
31 May 23 | 822 | -23 | 284 | 26 |
28 Feb 23 | 721 | -13 | 267 | 23 |
30 Nov 22 | 631 | -16 | 185 | 20 |
31 Aug 22 | 531 | 36 | 145 | 18 |
31 May 22 | 527 | 48 | 142 | 17 |
28 Feb 22 | 514 | 49 | 154 | 17 |
30 Nov 21 | 503 | 57 | 133 | 17 |
31 Aug 21 | 487 | 62 | 128 | 17 |
31 May 21 | 468 | 61 | 122 | 16 |
28 Feb 21 | 450 | 61 | 120 | 16 |
30 Nov 20 | 433 | 60 | 114 | 15 |
31 Aug 20 | 426 | 61 | 113 | 15 |
31 May 20 | 418 | 59 | 114 | 15 |
29 Feb 20 | 419 | 59 | 114 | 15 |
30 Nov 19 | 417 | 60 | 112 | 14 |
31 Aug 19 | 416 | 60 | 112 | 14 |
31 May 19 | 414 | 60 | 111 | 13 |
28 Feb 19 | 413 | 62 | 109 | 11 |
30 Nov 18 | 410 | 65 | 109 | 11 |
31 Aug 18 | 403 | 66 | 107 | 11 |
31 May 18 | 398 | 63 | 105 | 11 |
28 Feb 18 | 389 | 58 | 104 | 11 |
30 Nov 17 | 382 | 52 | 102 | 11 |
31 Aug 17 | 372 | 46 | 99 | 11 |
31 May 17 | 358 | 44 | 94 | 10 |
28 Feb 17 | 353 | 41 | 95 | 10 |
30 Nov 16 | 341 | 39 | 93 | 10 |
31 Aug 16 | 330 | 37 | 90 | 10 |
31 May 16 | 321 | 37 | 87 | 10 |
29 Feb 16 | 310 | 36 | 84 | 10 |
30 Nov 15 | 301 | 35 | 81 | 10 |
31 Aug 15 | 290 | 34 | 79 | 10 |
31 May 15 | 283 | 34 | 77 | 10 |
28 Feb 15 | 272 | 32 | 75 | 9 |
30 Nov 14 | 265 | 31 | 75 | 9 |
31 Aug 14 | 256 | 29 | 73 | 9 |
31 May 14 | 247 | 28 | 71 | 8 |
28 Feb 14 | 236 | 28 | 68 | 8 |
30 Nov 13 | 225 | 28 | 65 | 8 |
31 Aug 13 | 216 | 28 | 63 | 8 |
31 May 13 | 208 | 27 | 61 | 8 |
Ingresos de calidad: NEOG has a large one-off loss of $63.7M impacting its last 12 months of financial results to 29th February, 2024.
Margen de beneficios creciente: NEOG became profitable in the past.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: NEOG's earnings have declined by 37.7% per year over the past 5 years.
Acelerando crecimiento: NEOG has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Beneficios vs. Industria: NEOG has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de NEOG (0.05%) se considera baja.